Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes

被引:110
作者
Feng, Xingmin [1 ]
Scheinberg, Phillip [1 ]
Wu, Colin O. [2 ]
Samsel, Leigh
Nunez, Olga [1 ]
Prince, Courtney [3 ]
Ganetzky, Rebecca D. [4 ]
McCoy, J. Philip, Jr.
Maciejewski, Jaroslaw R. [3 ]
Young, Neal S. [1 ]
机构
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Off Biostat Res, NIH, Bethesda, MD 20892 USA
[3] Cleveland Clin, Dept Translat Hematol Oncol Res, Taussig Canc Ctr, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 04期
基金
美国国家卫生研究院;
关键词
cytokine; aplastic anemia; myelodysplastic syndromes; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; ANTITHYMOCYTE GLOBULIN; PLASMA THROMBOPOIETIN; PATHOPHYSIOLOGY; ERYTHROPOIETIN; CYCLOSPORINE; EXPRESSION; MARROW;
D O I
10.3324/haematol.2010.030536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although aplastic anemia and myelodysplasia have been extensively investigated, little is known about their circulating cytokine patterns. We compared plasma soluble cytokines in 33 aplastic anemia, 57 myelodysplasia patients, and 48 healthy controls. High levels of thrombopoietin and granulocyte colony-stimulating factor, with low levels of CD40 hgand, chemokine (C-X-C motif) ligand 5, chemokine (C-C motif) ligand 5, chemokine (C-X-C motif) ligand 11, epidermal growth factor, vascular endothelial growth factor, and chemokine (C-C motif) ligand 11 were a signature profile for aplastic anemia. High levels of tumor necrosis factor-a, interleukin-6, chemokine (C-C motif) ligand 3, interleukin-1 receptor antagonist, and hepatocyte growth factor were a cytokine signature for myelodysplasia. Despite similar clinical presentations, distinct cytokine profiles were observed between aplastic anemia and hypocellular myelodysplasia. Future studies focusing on cytokines that better discriminate these two entities such as thrombopoietin and chemokine (C-C motif) ligand 3 may be useful tools in clinical practice.
引用
收藏
页码:602 / 606
页数:5
相关论文
共 16 条
[1]  
Barrett J, 2000, SEMIN HEMATOL, V37, P15
[2]   Transcriptional regulation of the human MIP-1α promoter by RUNX1 and MOZ [J].
Bristow, CAP ;
Shore, P .
NUCLEIC ACIDS RESEARCH, 2003, 31 (11) :2735-2744
[3]  
Cheson BD, 2000, BLOOD, V96, P3671
[4]   Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells [J].
Hirayama, Y ;
Sakamaki, S ;
Matsunaga, T ;
Kuga, T ;
Kuroda, H ;
Kusakabe, T ;
Sasaki, K ;
Fujikawa, K ;
Kato, J ;
Kogawa, K ;
Koyama, R ;
Niitsu, Y .
BLOOD, 1998, 92 (01) :46-52
[5]  
KAUSHANSKY K, 1988, J IMMUNOL, V141, P3410
[6]   Measurement of endogenous plasma thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme-linked immunosorbent assay [J].
Kojima, S ;
Matsuyama, T ;
Kodera, Y ;
Tahara, T ;
Kato, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (03) :538-543
[7]   Measurement of endogenous plasma granulocyte colony-stimulating factor in patients with acquired aplastic anemia by a sensitive chemiluminescent immunoassay [J].
Kojima, S ;
Matsuyama, T ;
Kodera, Y ;
Nishihira, H ;
Ueda, K ;
Shimbo, T ;
Nakahata, T .
BLOOD, 1996, 87 (04) :1303-1308
[8]  
LINENBERGER ML, 1995, EXP HEMATOL, V23, P1104
[9]   Serum thrombopoietin levels in patients with aplastic anaemia [J].
Marsh, JCW ;
Gibson, FM ;
Prue, RL ;
Bowen, A ;
Dunn, VT ;
Hornkohl, AC ;
Nichol, JL ;
GordonSmith, EC .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (04) :605-610
[10]   INTENSIVE IMMUNOSUPPRESSION WITH ANTITHYMOCYTE GLOBULIN AND CYCLOSPORINE AS TREATMENT FOR SEVERE ACQUIRED APLASTIC-ANEMIA [J].
ROSENFELD, SJ ;
KIMBALL, J ;
VINING, D ;
YOUNG, NS .
BLOOD, 1995, 85 (11) :3058-3065